IMR Press / CEOG / Volume 27 / Issue 3-4 / pii/2000067

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research

Hepatic and renal effects of azidothymidine and acyclovir on pregnant rats

Show Less
1 Universidade de Mogi das CruzeS, School of Medicine (Brazil)
2 Institute of Biomedical Sciences, Universidade de Scio Pãulo (Brazil)
3 Universidade Federal de São Paulo School of Medicine, Brazil
4 Fundçao ABC School of Medicine, Brazil
Clin. Exp. Obstet. Gynecol. 2000, 27(3-4), 227–230;
Published: 10 September 2000
Abstract

The antiviral effect of azidothymidine (AZT) can be potentiated by acyclovir (ACY), and this drug association has been used m the management of HIV-infected patients. In the present study we examined the effects of this association on the livers and kidneys of both pregnant rats and their concepts. Previous data from this laboratory suggested that the deleterious effects of ACY on rat pregnancy are due to its extraplacental actions and these are, at least in part, counteracted by concomitant treatment with AZT Kidneys and livers of pregnant rats were noticed to be much more sensitive to the toxic action of the drugs than those of their concepts, ACY eliciting much more evident morphological alterations than did AZT Contrary to what was expected, in the group of rats treated with both drugs AZT was not able to diminish the severity of the alterations evoked by ACY. The proposed "protective" action of AZT against the abortive effect of ACY on rat pregnancy does not seem to be exerted through a renal or hepatic pathway. 

Keywords
Rat pregnancy
Azidothymidine
Acyclovir
Kidney
Liver
Share
Back to top